Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Report

Global and Region Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：171
  • REPORT CODE：GMM968821
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Staphylococcus aureus is bacteria usually found on nose or skin of healthy people. Methicillin-resistant staphylococcus aureus (MRSA) is a type of staphylococcus aureus which is resistant to methicillin, a beta-lactam antibiotic. The MRSA strains do not give response to methicillin treatment.

    The report details the trend, potential and market size of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugsmarket, defines the market attractiveness level of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs industry, describes the types of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market and the development prospects and opportunities of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market in Chapter 13.

    By Player:

    • Merck

    • Basilea Pharmaceutica

    • Theravance Biopharma

    • 3M

    • Allergan

    • Pfizer

    • Medicines Company

    By Type:

    • Oxazolidinone

    • Lipopeptide

    • Cephalosporin

    • Tetracycline

    • Folate Antagonists

    • Lipoglycopeptide

    • Other Drug Classes

    By End-User:

    • Oral

    • Parenteral

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.2 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.4 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.5 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.6 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    • 7.7 South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption (2017-2022)

    8 Region and Country-wise Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast (2022-2028)

    9 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oxazolidinone Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lipopeptide Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Cephalosporin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Tetracycline Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Folate Antagonists Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Lipoglycopeptide Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Other Drug Classes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Parenteral Consumption and Growth Rate (2017-2022)

    10 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Oxazolidinone Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Lipopeptide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Tetracycline Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Folate Antagonists Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Lipoglycopeptide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)

    11 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.2 Basilea Pharmaceutica

      • 14.2.1 Basilea Pharmaceutica Company Details

      • 14.2.2 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.3 Theravance Biopharma

      • 14.3.1 Theravance Biopharma Company Details

      • 14.3.2 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.4 3M

      • 14.4.1 3M Company Details

      • 14.4.2 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.5 Allergan

      • 14.5.1 Allergan Company Details

      • 14.5.2 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Details

      • 14.6.2 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • 14.7 Medicines Company

      • 14.7.1 Medicines Company Company Details

      • 14.7.2 Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs

    • Figure Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Picture

    • Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption by Country (2017-2022)

    • Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxazolidinone Consumption and Growth Rate (2017-2022)

    • Figure Global Lipopeptide Consumption and Growth Rate (2017-2022)

    • Figure Global Cephalosporin Consumption and Growth Rate (2017-2022)

    • Figure Global Tetracycline Consumption and Growth Rate (2017-2022)

    • Figure Global Folate Antagonists Consumption and Growth Rate (2017-2022)

    • Figure Global Lipoglycopeptide Consumption and Growth Rate (2017-2022)

    • Figure Global Other Drug Classes Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Parenteral Consumption and Growth Rate (2017-2022)

    • Figure Global Oxazolidinone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipopeptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cephalosporin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tetracycline Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Folate Antagonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipoglycopeptide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table Basilea Pharmaceutica (Foundation Year, Company Profile and etc.)

    • Table Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Basilea Pharmaceutica Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table Theravance Biopharma (Foundation Year, Company Profile and etc.)

    • Table Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table 3M (Foundation Year, Company Profile and etc.)

    • Table 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3M Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service

    • Table Medicines Company (Foundation Year, Company Profile and etc.)

    • Table Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Medicines Company Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US